97.53
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $97.53, with a volume of 5.85M.
It is down -1.18% in the last 24 hours and down -2.10% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$98.69
Open:
$98.95
24h Volume:
5.85M
Relative Volume:
0.92
Market Cap:
$125.03B
Revenue:
$34.76B
Net Income/Loss:
$4.79B
P/E Ratio:
26.35
EPS:
3.7017
Net Cash Flow:
$5.21B
1W Performance:
+1.54%
1M Performance:
-2.10%
6M Performance:
+9.58%
1Y Performance:
+17.96%
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big - TechStock²
Kesler Norman & Wride LLC Increases Stock Position in Medtronic PLC $MDT - MarketBeat
Oregon Public Employees Retirement Fund Boosts Holdings in Medtronic PLC $MDT - MarketBeat
Nisa Investment Advisors LLC Reduces Stock Holdings in Medtronic PLC $MDT - MarketBeat
How analysts rate Medtronic plc stock todayPortfolio Growth Summary & Accurate Intraday Trade Tips - ulpravda.ru
A Glimpse Into The Expert Outlook On Medtronic Through 13 Analysts - Benzinga
MDT: Bernstein Raises Price Target for Medtronic | MDT Stock New - GuruFocus
Bernstein Adjusts Price Target on Medtronic to $112 From $111, Maintains Outperform Rating - MarketScreener
Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026? - The Chronicle-Journal
Pulse Oximeters Market at the Heart of Remote Care: A USD 6.76 Billion Growth Opportunity by 2034 - GlobeNewswire Inc.
Why Medtronic plc stock attracts high net worth investorsDollar Strength & Breakout Confirmation Alerts - ulpravda.ru
Barclays Raises Price Target for Medtronic (MDT) to $116 | MDT S - GuruFocus
How Medtronic plc. Ordinary Shares stock trades under stagflation2025 Trade Ideas & Safe Entry Point Identification - ulpravda.ru
Is Medtronic plc stock a buy for dividend growthJuly 2025 Market Mood & Growth Focused Entry Point Reports - ulpravda.ru
Why analysts recommend Medtronic plc (2M6) stock2025 Investor Takeaways & Target Return Focused Stock Picks - ulpravda.ru
Medtronic’s diabetes unit MiniMed files for IPO - MSN
Robeco Institutional Asset Management B.V. Grows Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Purchased by Cerity Partners LLC - MarketBeat
Medtronic Stock Under the Microscope: Defensive Giant, Restless Investors - AD HOC NEWS
Medtronic PLC (NYSE:MDT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Medtronic Announces First Commercial Use of Thrombectomy System - Diagnostic and Interventional Cardiology
Study showed MiniMed 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus - Investing News Network
Medtronic insulin system maintains glucose control despite missed doses By Investing.com - Investing.com UK
New insulin pump tech keeps diabetes in check even when users forget a dose - Stock Titan
KLP Kapitalforvaltning AS Has $44.97 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Sivik Global Healthcare LLC Has $5.71 Million Stake in Medtronic PLC $MDT - MarketBeat
Medtronic (MDT) Valuation Check After Analyst Upgrade And New Hugo And Symplicity Spyral Milestones - Sahm
Medtronic PLC $MDT Shares Bought by MassMutual Private Wealth & Trust FSB - MarketBeat
Medtronic (MDT) Valuation Check After William Blair Upgrade And Key Hugo And Symplicity Spyral Milestones - Yahoo Finance UK
William Blair Upgrades Medtronic (MDT) - Nasdaq
Why Is Medtronic Stock Trading Higher After Analyst Upgrade - Benzinga
Medtronic (MDT) Upgraded to Outperform by William Blair | MDT St - GuruFocus
Why Medtronic plc stock could outperform in 2025Growth vs. Value Investing & Next-Level Stock Intelligence, Now Free - bollywoodhelpline.com
William Blair upgrades Medtronic stock rating to Outperform from Market Perform - Investing.com UK
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson - The Globe and Mail
Commonwealth Equity Services LLC Reduces Stock Holdings in Medtronic PLC $MDT - MarketBeat
Why Has Medtronic's Share Price Increased Following Analyst Upgrade - bitget.com
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference - PR Newswire
Medtronic Benefits Are Built for Every Chapter - CSRwire
Medtronic stock holds steady as Piper Sandler maintains Neutral rating By Investing.com - Investing.com UK
D.A. Davidson & CO. Has $20.33 Million Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly - simplywall.st
The Truth About Medtronic plc: Is This ‘Boring’ Stock Actually a Silent Flex? - AD HOC NEWS
Medtronic plc (MDT) Stock Analysis: Navigating a 15.53% Upside Potential in the Dynamic Medical Devices Sector - DirectorsTalk Interviews
Asset Management One Co. Ltd. Has $56.11 Million Stake in Medtronic PLC $MDT - MarketBeat
Davis Capital Management Makes New $1.26 Million Investment in Medtronic PLC $MDT - MarketBeat
Capital Advisors Inc. OK Raises Stake in Medtronic PLC $MDT - MarketBeat
Synergy Asset Management LLC Acquires 128,899 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Purchased by Generali Asset Management SPA SGR - MarketBeat
Wall Street Zen Downgrades Medtronic (NYSE:MDT) to Hold - MarketBeat
Lazard Freres Gestion S.A.S. Boosts Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):